Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,141 headlines found

5 Views

Chantix, Zyban Lose Boxed Warning on Psych Effects

The FDA said it was persuaded by results from a trial called EAGLES that found that these psychiatric events were no more common with varenicline or bupropion compared with individuals using nicotine patches or placebo to try to quit smoking. The FDA had
MedPage Today
added Dec 17, 2016 15:46
1 View

US drops bold warning from anti-smoking pills Chantix, Zyban

The FDA decision stems from an 8,000-patient study of smokers that found no elevated risk of psychiatric problems among Chantix users who had no prior history of mental illness. European regulators previously removed their own warning from the drug based
AP - Associated Press
added Dec 17, 2016 06:47
4 Views

FDA drops black box warning on Pfizer's anti-smoking drug

allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial drug that was approved a decade ago. The U.S. Food and Drug Administration slapped a "black box" wa
Reuters
added Dec 16, 2016 19:39
3 Views

FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling

Labeling Revisions Also Include Updates to Corresponding Warning and Addition of Clinical Data on Superior Efficacy of CHANTIX Compared to Bupropion or Nicotine Patch1
Business Wire
added Dec 16, 2016 19:37
4 Views

A Hot Souvenir From Cuba for Some Americans: Cancer Vaccine

Cimavax is a therapeutic vaccine developed not to prevent cancer, but to halt its growth and keep it from recurring in patients with non-small-cell lung cancer. Developed in Cuba and available to patients there since 2011, it works by targeting a protein
New York Times
added Nov 14, 2016 14:28
7 Views

Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit

Wall Street analysts estimate that Chantix’s sales in 2016 will reach ~$0.9 billion, which would be a year-over-year (or YoY) decline of ~28%. The strong growth is mainly attributed to robust sales anticipated in the US market due to increasing demand an
Market Realist
added Oct 22, 2016 20:27
7 Views

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Many of these products are in the early stages of clinical trials; however, cytisine looks most promising in having established efficacy and safety with low cost. Electronic cigarettes have become very popular, appear to be efficacious and are safer than
CNS Drugs
added Oct 7, 2016 17:32
7 Views

[Canada] This may be exactly what smokers need to quit

Le and his team are proposing to develop a new vaccination strategy targeting the lungs, which offers an effective treatment that can sequester nicotine in the airways and limit its entry into the brain. Preliminary results show that levels of nicotine
BayToday.ca (ca)
added Sep 30, 2016 22:10
1 View

Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking
PR Newswire
added Sep 30, 2016 02:10
2 Views

FDA panel recommends dropping serious warning on Pfizer's Chantix

A serious warning on Pfizer Inc's quit smoking drug should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data on the controversial treatment.
Reuters
added Sep 15, 2016 22:11
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines